Header Logo

Connection

WARREN C FISKUS to Point Mutation

Back to Details
This is a "connection" page, showing publications WARREN C FISKUS has written about Point Mutation.
WARREN C FISKUS
Connection Strength
0.013
Point Mutation
  1. Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. Blood. 2005 Feb 15; 105(4):1768-76.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.